Atavistik Bio is a new, privately-held biopharmaceutical company focused on the discovery and development of novel therapies for metabolic diseases and cancer. Our high-throughput platform for the unbiased identification of metabolite-protein interactions will enable the discovery of first-in-class drugs inspired and empowered by nature’s own mechanisms of allosteric control. Our unique approach marries this validated platform with structure-aided drug design capabilities and cutting-edge insights into the regulation of metabolic systems to apply to genetically validated targets.
Atavistik Bio Address
75 Sidney Street Cambridge, MA
Atavistik Bio Email
Past Companies
Atavistik BioSenior VP of Platform
Atavistik BioSenior VP of Metabolism and Protein Sciences
Agios PharmaceuticalsVP of Metabolism and Proteomics and External Innovation Lead